ArticleFrontiers in oncology2025
Effect of short-term oral nutrients after hospital discharge on postoperative muscle loss and survival in gastric cancer patients.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: A decrease in skeletal muscle mass in patients with gastric cancer following surgery is closely related to tumor recurrence and poor prognosis. Postoperative enteral nutrition support can accelerate the postoperative recovery of patients with gastric cancer. We aimed to analyze the effectiveness of short-term oral nutritional supplements(ONS) in attenuating postoperative skeletal muscle mass loss in gastric cancer patients after hospital discharge and the impact on long-term prognosis. Methods: This study included patients who underwent radical gastrectomy at our center between 2014 and 2019. Univariate and multivariate logistic regression analyses were used to analyze the effectiveness of short-term oral nutrition for reducing postoperative skeletal muscle mass loss in patients with gastric cancer. Using cox regression to analyze the effect of ONS and each covariate on overall survival (OS). Results: ONS attenuated postoperative skeletal muscle loss, and it can improve the prognosis of patients, especially the elderly, those with poor nutritional status, anemia, and patients who have undergone total gastrectomy. Conclusions: Short-term oral nutrition is an independent protective factor for preventing skeletal muscle mass loss in patients with gastric cancer after surgery. Oral nutrition after surgery can reduce short-term muscle mass loss and is helpful in lowering the risk of death for patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.